Osvaldo Andrade Santos Filho

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Pesquisas de Produtos Naturais

Departamento:

Programa de Produtos Naturais/IPPN

ORCID:

https://orcid.org/0000-0001-7407-158X


Formação:
  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2008 - 2009
  • The University of Illinois at Chicago

    | Pós-Doutorado | 2002 - 2006
  • Universidade Federal do Rio de Janeiro

    | Pós-Doutorado | 2000 - 2002
  • Instituto Militar de Engenharia

    Química | Doutorado | 1996 - 2000
  • Universidade Federal do Rio de Janeiro

    Engenharia Econômica e Administração Industrial | Especialização | 1994 - 1995
  • Instituto Militar de Engenharia

    Química | Mestrado | 1994 - 1996
  • Faculdade Béthencourt da Silva

    Docência Superior | Especialização | 1993 - 1994
  • Faculdades Reunidas Nuno Lisboa

    Quimica Industrial | Graduação | 1988 - 1992
  • Colégio Pedro II

    | Ensino Médio (2o grau) | 1984 - 1986
  • Colégio Pedro II

    | Ensino Fundamental (1o grau) | 1980 - 1983
  • Escola Municipal Suécia

    | Ensino Fundamental (1o grau) | 1977 - 1979
Laboratórios:
Nuvens de Palavras:
Artigos:

(90.00% artigos com DOI)

Titulo DOI Ano
Solidagenone from Solidago chilensis Meyen Protects against Acute Peritonitis and Lipopolysaccharide-Induced Shock by Regulating NF-κB Signaling Pathway 10.3390/ph17030273 2024
Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity 10.1002/ardp.202300440 2024
Pharmacophore Virtual Screening Identifies Riboflavin as an Inhibitor of the Schistosome Cathepsin B1 Protease with Antiparasitic Activity 10.1021/acsomega.4c03376 2024
Novel Centratherin Derivatives: Molecular Docking Design, Asymmetric Synthesis, and Antitumoral Activity 10.1016/j.tet.2024.134112 2024
Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication 10.1021/acs.jnatprod.3c00249 2023
Identification of Potential Allosteric Site Binders of Indoleamine 2,3-Dioxygenase 1 from Plants: A Virtual and Molecular Dynamics Investigation 10.3390/ph15091099 2022
Identification of Potential Inhibitors of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Main Protease from Non-Natural and Natural Sources: A Molecular Docking Study 10.21577/0103-5053.20200139 2020
Pharmacological profiling of JME-173, a novel mexiletine derivative combining dual anti-inflammatory/anti-spasmodic functions and limited action in Na+ channels 10.1016/j.ejphar.2020.173367 2020
Geissoschizoline, a promising alkaloid for Alzheimer?s disease: Inhibition of human cholinesterases, anti-inflammatory effects and molecular docking 10.1016/j.bioorg.2020.104215 2020
Solution and Solid State Nuclear Magnetic Resonance Spectroscopic Characterization of Efavirenz 10.1016/j.xphs.2015.10.006 2016
Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin 10.1371/journal.pone.0139236 2015
1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses 10.1016/j.bmc.2015.11.028 2015
Design, synthesis, and antiviral activity of new 1H-1,2,3-triazole nucleoside ribavirin analogs 2014
Synthesis of simple molecules prepared as arginase inhibitors and evaluated against Leishmania amazonensis 2013
Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection 10.1016/j.foodchem.2013.05.025 2013
Inhibition of Leishmania (Leishmania) amazonensis and Rat Arginases by Green Tea EGCG, (+)-Catechin and (−)-Epicatechin: A Comparative Structural Analysis of Enzyme-Inhibitor Interactions 10.1371/journal.pone.0078387 2013
Synthesis of ß-Substituted Porphyrin Derivatives Containing Heterocyclic Moieties as Potential Photosensitizers Against Cutaneous Leishmaniasis 10.1002/ejoc.201201501 2013
New Trifluoromethyl Triazolopyrimidines as Anti-Plasmodium falciparum Agents 10.3390/molecules17078285 2012
CoMFA/CoMSIA 3D-QSAR of pyrimidine inhibitors of Pneumocystis carinii dihydrofolate reductase 10.1007/s00894-012-1399-y 2012
Mapping the Protein Interaction Network in Methicillin-Resistant 10.1021/pr100918u 2011
Design and Synthesis of New N-(5-Trifluoromethyl)-1H-1,2,4-triazol-3-yl Benzenesulfonamides as Possible Antimalarial Prototypes 10.3390/molecules16098083 2011
In silico identification of anthropogenic chemicals as ligands of zebrafish sex hormone binding globulin 10.1016/j.taap.2008.07.014 2009
The Receptor-Dependent QSAR Paradigm: An Overview of the Current State of the Art 2009
An Updated Steroid Benchmark Set and Its Application in the Discovery of Novel Nanomolar Ligands of Sex Hormone-Binding Globulin 10.1021/jm7011485 2008
Combined 4D-fingerprint and clustering based membrane-interaction QSAR analyses for constructing consensus Caco-2 cell permeation virtual screens 10.1002/jps.21086 2008
Categorical QSAR models for skin sensitization based on local lymph node assay measures and both ground and excited state 4D-fingerprint descriptors 10.1007/s10822-008-9190-y 2008
Using Molecular Docking, 3D-QSAR, and Cluster Analysis for Screening Structurally Diverse Data Sets of Pharmacological Interest 10.1021/ci8001952 2008
Structure-Based QSAR Analysis of a Set of 4-Hydroxy-5,6-dihydropyrones as Inhibitors of HIV-1 Protease:  An Application of the Receptor-Dependent (RD) 4D-QSAR Formalism 10.1021/ci050326x 2006
Molecular dynamics simulations of a set of isoniazid derivatives bound to InhA, the enoyl-acp reductase fromM. tuberculosis 10.1002/qua.21055 2006
A complete model of the Plasmodium falciparum bifunctional enzyme dihydrofolate reductase-thymidylate synthase: a model to design new antimalarials 10.1590/S0103-50532004000300019 2004
Rational Design of New Antituberculosis Agents:  Receptor-Independent Four-Dimensional Quantitative Structure?Activity Relationship Analysis of a Set of Isoniazid Derivatives 10.1021/jm049913k 2004
Characterization of Skin Penetration Processes of Organic Molecules Using Molecular Similarity and QSAR Analysis 10.1021/mp049924+ 2004
Modelagem de proteínas por homologia 10.1590/S0100-40422003000200019 2003
The 4D-QSAR Paradigm: Application to a Novel Set of Non-peptidic HIV Protease Inhibitors 2002
Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR 10.1016/S0301-4622(02)00077-7 2002
Type 2 antifolates in the chemotherapy of falciparum malaria 10.1590/S0103-50532002000600003 2002
A search for sources of drug resistance by the 4D-QSAR analysis of a set of antimalarial dihydrofolate reductase inhibitors 10.1023/A:1011152818340 2001
Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance 10.1016/S0301-4622(01)00180-6 2001
Free energy force field (FEFF) 3D-QSAR analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors 10.1023/A:1013199108020 2001
Molecular modeling of the interaction of trypanocide guanyl hydrazones with B-DNA 10.1016/S0960-894X(97)00312-0 1997
Eventos:

(4.17% eventos com DOI)

Titulo DOI Ano
Virtual Screening and Drug Repurposing: Together Against Worm-Borne Diseases 2022
Potential Inhibitors of helminths Cathepsin B1: Riboflavin 2022
Evaluation of aryl amidines/benzimidazoles as potential anti-COVID-19 agents: A computational study 10.3390/ECMC2020-07288 2020
XXIX Annual Meeting of the Brazilian Society of Protozoology / XL Annual Meeting on Basic Research in Chagas' Disease 2013
Investigação espectroscópica do efavirenz por RMN de solidos e em solução 2012
Design, síntese e avaliação antimalárica de novos derivaos triazolopirimidínicos 2011
Design e síntese de análogos de ribavirina com potencial antividade anti-HIV 2011
Design e síntese de novos derivados sulfonamídicos com potencial atividade Leishmanicida 2011
Design e Sintese de Novos Nucleosídeos como Antivirais Análogos da Ribavirina 2010
Searching for new antileishmaniasis lead molecules: synthesis and molecular modeling of new ethyl 7-aryl-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-5-carboxylate derivatives 2010
3D-QSAR CoMFA Study of pteridine derivatives inhibitors of Pneumocystis carinii dihydrofolate reductase 2010
Modelagem comparativa e dinâmica molecular dos dominios transmembranares de VEGFR1, VEGFR2 e VEGFR3 2009
Constructing Protein Pruning Models to Perform Receptor-Dependent (RD) 4D-QSAR analysis of a Set of Diazaborine Derivatives 2005
Planejamento Direto de Tuberculostaticos Potenciais 1. Aplicacao do Formalismo QSAR-4D em Derivados de Isoniazida 2003
Planejamento Direto de Tuberculostaticos Potenciais 2. Aplicacao do Formalismo FEFF 3D-QSAR DR em Derivados de Isoniazida 2003
Modelagem Molecular no Planejamento de Potenciais Antimalariais 2001
4D-QSAR Analysis: Application to a Set of HIV Protease Inhibitors 2001
Generation and Topological Molecular Modeling Study of Wild-Type and Mutant Plasmodium falciparum DHFR 2001
Homology Modeling of Dihydrofolate Reductase-Tymidilate Synthase of Plasmodium falciparum: Apotential Model to Design New Antimalarials 2001
4D-QSAR of Plasmodium falciparum Dihydrofolate Reductase Inhibitors 2000
Homology Modeling of Plasmodium falciparum Dihydrofolate Reductase. A Tool for the Design of Antimalarial Drugs 1999
Homology Modeling of Plsmodium falciparum Dihydrofolate Reductase 1999
Molecular Modeling of the Interaction of Trypanocide Guanyl Hydrazones with B-DNA 1996
Estudo Conformacional de Guanil Hidrazonas Potencialmente Ativas contra o Trypanossoma cruzi 1995
Publicações:
Minha Rede: